Efficacy of Probiotics on Physical Performance | NCT03259997

Studies
Efficacy of Probiotics on Physical Performance

NCT03259997

Sponsor

Probi AB

Status

Completed

Last Update Posted

Mar 20, 2019Actual

Enrollment

53Actual

Phase

Not Applicable

Conditions

Physical Performance

Interventions

Probiotic supplement
Placebo

Countries

Sweden

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Mar 2019

Overall Recruitment Status or Expanded Access Status

Completed

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Aug 14, 2017Actual

Primary Completion Date

May 9, 2018Actual

Completion Date

May 9, 2018Actual

First Submitted Date

Aug 17, 2017

First Submission Date that Met QC Criteria

Aug 21, 2017

First Posted Date

Aug 24, 2017Actual

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Mar 19, 2019

Last Update Posted Date

Mar 20, 2019Actual

Oversight Module

Has Data Monitoring Committee (DMC)

Is FDA Regulated Drug

Is FDA Regulated Device

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Design Module

Study Type

Interventional

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Not provided

Target Follow-Up Duration

Not provided

Phases

Not Applicable

Interventional Study Design

Allocation

Biospecimen

No data available

No data is available for this block.

Enrollment

53Actual

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
Probiotic supplement	Active Comparator		Dietary Supplement: Probiotic supplement
Placebo	Placebo Comparator		Dietary Supplement: Placebo

Interventions

Name	Type	Description	Arm Group Labels	Other Names
Probiotic supplement	Dietary Supplement	Probiotic supplement	Probiotic supplement

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Metabolic response at standardized workloads during ergometer cycling	Change from baseline in metabolic response at standardized workloads during ergometer cycling after 4,8 and 12 weeks of supplementation	4,8 and 12 weeks

Secondary Outcomes

Not provided

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Male or female, aged 18 to 40 years, at the time of signing the informed consent form
Provides signed and dated informed consent form
Engaged in competitive sports and regularly training
Non-anemic, iron-deficient
Willing to comply with all study procedures and be available for the duration of the study

Exclusion Criteria:

Use of probiotics
Use of iron supplementation
Use of ascorbic acid (Vitamin C) supplementation
Hypersensitivity to any of the ingredients in the investigational product (IP)

Accepts Healthy Volunteers

Yes

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

18 Years

Maximum Age

40 Years

Standard Ages

Adult

Study Population

Not provided

Sampling Method

Not provided

Contacts/Locations Module

Central Contacts

Not provided

Overall Officials

Name	Affiliation	Role
Michael Svensson, PhD	Umeå University	Principal Investigator

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Idrottsmedicinska enheten, Umeå universitet		Umeå		90187	Sweden

IPD Sharing Statement Module

Plan to Share IPD

Description

Not provided

Types

Not provided

Time Frame

Not provided

Access Criteria

Not provided

URL

Not provided